trial

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

NCTId NCT03061136
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Withdrawn
Enrollment 0 (actual)
Sponsored by Palo Alto Veterans Institute for Research
Primary completion 2017-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2016-10
Primary completion
2017-10
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Clonazepam

Sponsors

Palo Alto Veterans Institute for ResearchLead Sponsor
Stanford UniversityCollaborator
University of California Riverside at C.I. Trials, Inc.-Inland EmpireCollaborator

Sites

1 total
Palo Alto, United States

Facts & assertions

4 sourced
Enrollment
0
Phase
PHASE4
Primary Completion Date
2017-10
Status
WITHDRAWN
relationships
The graph out of here
drug
Clonazepam
drug
lead_sponsor
Palo Alto Veterans Institute for Research
company
collaborator
Stanford University
company
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication